FindTrial
Sign In

Comparison of Vasopressin and Normal Saline in Laparoscopic Endometrioma excision on ovarian reserve

A study of Ovarian reserve in laparoscopic excision of ovarian endometrioma compaing the effect of Vasopressin versus Normal Saline: A RANDOMISED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033292
Enrollment
70
Registered
2021-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N801- Endometriosis of ovary Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: vassopressin: 30-40 ml vasopressin diluted(1:20) injection will be given inta-ovarian during operative procedure frequency : once duration : one injection at time of excision Control I

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of reproductive age group (age 18-40 years) with unilateral or bilateral ovarian endometriosis measuring 3-8 cm at its greatest diameter diagnosed by ultrasound

Exclusion criteria

Exclusion criteria: History of previous ovarian surgery Patient with known contraindication to vasopressin. Intraoperative finding of cyst other than endometrioma. GnRH therapy within 6 months of surgery. Women with completed family. Patients refusal

Design outcomes

Primary

MeasureTime frame
AMH Day 2 FSH Timepoint: PREOPERATIVE MEASUREMENT 3 MONTH AFTER SURGERY—

Secondary

MeasureTime frame
1) AMOUNT OF BLOOD LOSS 2) DURATION AND NUMBER OF TIMES ELCTROCAUTERY WAS USED 3) OPERATIVE TIME 4) HEMOGLOBINTimepoint: 1) INTRAOPERATIVE: AMOUNT OF BLOOD LOSS, DURATION AND NUMBER OF TIMES ELCTROCAUTERY WAS USED, OPERATIVE TIME 2) SECOND POSTOPERATIVE DAY : HEMOGLOBIN—

Countries

India

Contacts

Public ContactDr Monika Anant

AIIMS PATNA

drmonikaanant@gmail.com7764946249

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026